---
title: 'Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective
  Study Including 472 146 Patients'
date: '2023-12-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38142444/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231225170704&v=2.18.0
source: heidelberg[Affiliation]
description: The aims of this study were to analyze proton pump inhibitor (PPI) users
  in Germany, defining and classifying them in terms of treatment appropriateness,
  and to analyze the PPI prescription practices of healthcare providers. The updated
  DGVS (Deutsche Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten)
  gastroesophageal reflux disease (GERD) treatment guideline (published March 2023)
  for mild heartburn symptoms recommends carrying out a probatory treatment of mild
  ...
disable_comments: true
---
The aims of this study were to analyze proton pump inhibitor (PPI) users in Germany, defining and classifying them in terms of treatment appropriateness, and to analyze the PPI prescription practices of healthcare providers. The updated DGVS (Deutsche Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten) gastroesophageal reflux disease (GERD) treatment guideline (published March 2023) for mild heartburn symptoms recommends carrying out a probatory treatment of mild ...